← Latest Filings
A
AH Equity Partners Bio II, L.L.C.
Open-market buys
1
$5.0M total
Open-market sells
2
$11.8M total
Tracking since
Jun 2026
Activity timeline
Open-market buy — $5.0M
Scribe Therapeutics, Inc. · Jul 27, 2026
Open-market sale — $902K
Nautilus Biotechnology, Inc. · Jun 2, 2026
Open-market trades from the last two years.
Holdings as last reported
11,682,032 Common Stock in NAUT
Held indirectly (By AH Bio Fund II, L.P.) · as of 2026-06-02
971,885 Common Stock in NAUT
Held indirectly (By Andreessen Horowitz LSV Fund II, L.P.) · as of 2026-06-02
Companies touched
Nautilus Biotechnology, Inc.
CIK 0001808805
